Quality of Life After Cardiac Surgery
Completed
- Conditions
- Mitral Valve DiseaseTricuspid Valve DiseaseAorta DiseaseCoronary Artery Bypass GraftAortic Valve Stenosis
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 2925
- Registration Number
- NCT04231461
- Locations
- π¬π§
Royal Papworth Hospital, Cambridge, Cambridgeshire, United Kingdom
Second Primary Lung Cancer Cohort Study (SPORT)
Recruiting
- Conditions
- Lung Cancer
- First Posted Date
- 2019-11-26
- Last Posted Date
- 2021-03-25
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 850
- Registration Number
- NCT04178889
- Locations
- π¬π§
Royal Papworth Hospital, Cambridge, United Kingdom
Developing a Non-contact Sleep Apnoea Detector, Suitable for Home Studies- The Safescan Study
Completed
- Conditions
- Obstructive Sleep ApnoeaSleep Apnoea
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 445
- Registration Number
- NCT04071860
- Locations
- π¬π§
Royal Papworth Hospital, Cambridge, Cambridgeshire, United Kingdom
Mathematically Arterialised Testing of Hypercapnic Subjects Study
Completed
- Conditions
- Hypercapnic Respiratory Failure
- First Posted Date
- 2019-08-28
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 84
- Registration Number
- NCT04072848
- Locations
- π¬π§
Royal Papworth Hospital, Cambridge, Cambridgeshire, United Kingdom
Functional Respiratory Imaging in Bronchiectasis
- Conditions
- Bronchiectasis
- First Posted Date
- 2019-01-28
- Last Posted Date
- 2019-01-28
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 10
- Registration Number
- NCT03818646
- Locations
- π¬π§
Royal Papworth Hospital NHS Foundation Trust, Papworth Everard, Cambridgeshire, United Kingdom
Validation Of Tidal/End -Tidal CO2 in ALS
- Conditions
- Motor Neuron DiseaseAmyotrophic Lateral Sclerosis
- First Posted Date
- 2018-12-05
- Last Posted Date
- 2021-03-10
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 200
- Registration Number
- NCT03764384
- Locations
- π¬π§
Royal Papworth NHS Foundation Trust, Papworth Everard, Cambridge, United Kingdom
Target Validation and Discovery in Idiopathic Bronchiectasis
Completed
- Conditions
- BronchiectasisIdiopathic Bronchiectasis
- Interventions
- Diagnostic Test: BronchoscopyDiagnostic Test: Blood test
- First Posted Date
- 2018-11-23
- Last Posted Date
- 2022-04-04
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 13
- Registration Number
- NCT03750734
- Locations
- π¬π§
Royal Papworth Hospital, Cambridge, United Kingdom
CASPA: CArdiac Sarcoidosis in PApworth
Completed
- Conditions
- Interstitial Lung DiseaseCardiac SarcoidosisPulmonary Sarcoidosis
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2023-06-18
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 104
- Registration Number
- NCT03599414
- Locations
- π¬π§
Royal Papworth Hospital, Papworth Everard, Cambridgeshire, United Kingdom
Algorithmic Protamine Dosing for Reversal of Heparin After Cardiopulmonary Bypass
Not Applicable
Completed
- Conditions
- Heart DiseasesCardiovascular Diseases
- Interventions
- Procedure: PRODOSE AlgorithmProcedure: Standard Care
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2020-06-23
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 228
- Registration Number
- NCT03532594
- Locations
- π¬π§
Royal Papworth Hospital NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom
Human Vasodilatory Effect of GLP-1
Not Applicable
Completed
- Conditions
- Coronary StenosisAngina, StableType2 Diabetes
- First Posted Date
- 2018-04-18
- Last Posted Date
- 2018-04-18
- Lead Sponsor
- Papworth Hospital NHS Foundation Trust
- Target Recruit Count
- 11
- Registration Number
- NCT03502083
Β© Copyright 2025. All Rights Reserved by MedPath